Search

1 to 4 of 4
Sort by

Library Entry
Emerging Issues in the Use of Unproven Cell-based Therapies

The provision of unproven cell interventions sold directly to consumers remains a global challenge, posing risks to patients and complicated the development of safe and effective proven cell therapies. Indeed, despite, or perhaps because of, increased scrutiny from regulatory bodies, the...

1311398.mp4



Library Entry
Cell, Tissue and Gene Products With Marketing Authorization

Prepared by the ISCT Presidential Task Force on the Use of Unproven and/or Unethical Cell & Gene Therapies. #Commercialization #UnprovenCellularTherapies #MarketAuthorizations #ExternalLink


Library Entry
Cell, Tissue and Gene Products With Marketing Authorization in 2018 Worldwide

Cell and gene therapies (CGTs) are progressively entering into clinical practice in different parts of the world. The International Society for Cell & Gene Therapy (ISCT), a global scientific society, has been committed since 1992 to supporting and developing knowledge on clinical...